🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an multicenter, randomized，double-blind, controlled clinical study....
Status
Completed
Location
Cancer Institute and Hospital , Chinese Academy of Medical Sciences
Start Date
2017-07-06
Trial ID
NCT06781073
Treatments Being Tested
Determination of efficiency of nimotuzumab in children with diffuse intrins...
Status
Completed
Location
University Bonn, Children's Medical Hospital
Start Date
2006-04
Trial ID
NCT00561691
Treatments Being Tested
Nimotuzumab (hR3) is an IgG1 humanized monoclonal antibody that recognized ...
Status
Withdrawn
Location
Cancer Institute & Hospital, Chinese Academy of Medical Sciences
Start Date
2009-09
Trial ID
NCT00985998
Treatments Being Tested
A multicenter, randomized, controlled, open-label, Phase II/III clinical tr...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-05-05
Trial ID
NCT07535567
Treatments Being Tested
The purpose of this study is to define the response and toxicities with the...
Status
Completed
Location
National Cancer Center Singapore
Start Date
2008-04-28
Trial ID
NCT00702481
Treatments Being Tested
Over-expression of Epidermal Growth Factor Receptor (EGFR) on cells occurs ...
Status
Recruiting
Location
Royal University Hospital
Start Date
2020-02-01
Trial ID
NCT04235114
Treatments Being Tested
Primary Objective:To evaluate the efficacy and safety of TIP (paclitaxel + ...
Status
Completed
Location
Sun Yat-sen University Cancer Center
Start Date
2020-08-12
Trial ID
NCT04475016
Treatments Being Tested
Nimotuzumab is a humanized monoclonal antibody against epidermal growth fac...
Status
Completed
Location
First Affiliated Hospital of Bengbu Medical College
Start Date
2015-04
Trial ID
NCT02395016
Treatments Being Tested
This trial is a retrospective, observational study, patients who underwent ...
Status
Completed
Location
Multiple Locations
Start Date
2016-05-01
Trial ID
NCT06363084
Treatments Being Tested
The aim of the study is to evaluate the role of nimotuzumab in the neo-adju...
Status
Completed
Location
Fudan University Cancer Hospital
Start Date
2009-05
Trial ID
NCT00910117
Treatments Being Tested